SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLASs REGAL Phase 3 AML trial reaching its 80th death event and entering final analysis has focused attention on the pending GPS results. Traders are divided over the steep selloff since the milestone was announced without data: some attribute it to short-selling and profit-taking, while others worry it signals adverse information; upcoming SLS009 results are a secondary catalyst.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvells agreed all-stock acquisition of Lumentum is driving attention, with many traders criticizing the deals dilution, price and long closing timeline as the shares sell off. Others argue the combination of Marvells connectivity chips and Lumentums optical technology could strengthen its position in AI data centers over the longer term.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Marvells agreed all-stock acquisition of Lumentum has put the fixed 4.5-for-1 share exchange in focus, tying LITEs value to Marvells stock price until the deal closes. The sharp selloff has fueled criticism that the terms leave Lumentum holders exposed to dilution and a long wait, while some traders see the decline as a buying opportunity.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples fiscal Q4 earnings report is the dominant focus, with traders watching holiday-quarter guidance, iPhone Duo demand and rising memory costs effect on margins. Views are split between optimism about product demand and Apples resilience, and concern that its elevated valuation leaves little room for disappointment.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs upcoming quarterly report is drawing attention after Intels weak outlook triggered a sharp selloff across chip stocks, with traders focused on whether AMDs results and guidance can distinguish it from broader concerns about PC demand and AI spending returns. Bulls argue Intels struggles could create share gains for AMD, while bears worry lofty expectations leave the stock vulnerable if the outlook disappoints.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costcos reported October retail-month sales growth of 8.6% is drawing attention, alongside bullish trading around a technical breakout and call-option activity. Traders also speculate about a special dividend, but no announcement is confirmed.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

Traders are focused on Compasss expected completion of the rolling COMP360 NDA submission, speculating that confirmation could start an accelerated FDA review; many are frustrated by the wait and see the filing update as a key catalyst. Recent weakness is attributed by some to broader biotech pressure, while Usonas parallel psilocybin filing raises competitive concerns for others; skeptics counter that Usona is pursuing MDD and lacks Compasss commercial infrastructure.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus is drawing attention after a stronger-than-expected third-quarter report and a raised full-year revenue outlook. Traders largely welcomed the results and the stocks move higher, though some questioned whether the gains would hold amid the names volatility.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracles planned equity and bond financing for its AI and data-center expansion is weighing on shares, with traders concerned about dilution, debt and whether heavy spending will generate returns. Bulls argue the financing was already outlined and could complete the current funding plan, while skeptics see its timing as a sign of mounting financial risk.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

AXSM is under pressure despite a stronger-than-expected quarterly report and continued AUVELITY growth, as investors focus on the lack of firm guidance, high expenses and uncertainty about the Alzheimers agitation launchs uptake and path to profitability. Traders are split between viewing the selloff as an overreaction and criticizing managements limited clarity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$CEG $FSLR $VST $BE so  much discussion about the need for power for AI infra etc over the next decade

StockTwits for iOS

Constellation Energy Corporation

First Solar Inc

Vistra Corp

Bloom Energy Corp - Ordinary Shares - Class A

 so  much discussion about the need for power for AI infra etc over the next decade

🌴

@Hollywood_1 Mid terms could jack some things marketvwise, but agree after dust settles.

StockTwits For Android 

 Mid terms could jack some things marketvwise, but agree after dust settles.